PMID: 34186022): The study showed HbA1c reduction of 1.87% , 1.89% , and 2.07% vs 0.04% placebo The study showed body weight reduction of 7.0-9.5 kg across dose groups The study showed up to 52% of patients achieved HbA1c below 5.7% at the 15 mg dose Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) , published in New England Journal of Medicine (Jastreboff AM et al., 2022
Badanie nie wykazao zmniejszenia ryzyka zachorowania na raka u pacjentw, a jedynie potencjalny mechanizm, dziki ktremu mona przywrci procesy przeciwnowotworowe
Header image photo: Kassandra, Adobe Stock
The role of Src kinase in macrophage-mediated inflammatory responses
1 racin = 2,5 cacitos = 2 g
UA (Aladdin, U105582), LC (Aladdin, C105423), and TMZ (Aladdin, T166941) were added to cells in the respective groups at the indicated concentrations